Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry
Background/Aims Long-term benefit of vasodilating β-blockers is unknown. This study aimed to investigate the long-term benefit of vasodilating β-blockers over conventional β-blockers in patients with acute myocardial infarction (AMI). Methods Using nationwide prospective multicenter Korean Acute Myo...
Main Authors: | Jaehoon Chung, Jung-Kyu Han, Han-Mo Yang, Kyung-Woo Park, Hyun-Jae Kang, Bon-Kwon Koo, Myung Ho Jeong, Hyo-Soo Kim, on behalf of investigators for Korea Acute Myocardial Infarction Registry (KAMIR) |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Association of Internal Medicine
2021-03-01
|
Series: | The Korean Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.kjim.org/upload/pdf/kjim-2020-135.pdf |
Similar Items
-
Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study
by: Jaehoon Chung, et al.
Published: (2017-10-01) -
Beta-blockers in the prevention and treatment of ischemic heart disease: Evidence and clinical practice
by: Omer Khan, et al.
Published: (2023-01-01) -
Mortality reduction with use of oral beta-blockers in patients with acute coronary syndrome
by: Alexandre de Matos Soeiro, et al. -
CARDIO-SELECTIVE Β-BLOCKER BISOPROLOL IN THE MANAGEMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2011-06-01) -
THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01)